Evidence map›Paper›PMID 40396033›Full record

ArticleAutophagy reports2022

Avobenzone, Guaiazulene and Tioxolone identified as potent autophagy inducers in a high-throughput image based screen for autophagy flux.

Surendra Kumar Prajapat, Chandru Subramani, Puja Sharma, Sudhanshu Vrati, Manjula Kalia

Abstract read
In one paragraph

Article in Autophagy reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Surendra Kumar PrajapatRegional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, 121001, Haryana, India.
Chandru SubramaniRegional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, 121001, Haryana, India.
Puja SharmaRegional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, 121001, Haryana, India.
Sudhanshu VratiRegional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, 121001, Haryana, India.
Manjula KaliaRegional Centre for Biotechnology, NCR Biotech Science Cluster, Faridabad, 121001, Haryana, India.ORCID https://orcid.org/0000-0002-3376-3659

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy is a conserved intracellular degradation pathway that is essential for maintaining cellular homeostasis. Given its critical role in several disease conditions, recent studies are focussed on identifying drugs/small molecules with autophagy modulating capacity for potential clinical applications. Here, we describe the development and characterisation of a quantitative image-based high content screening platform for autophagy flux measurements using the human melanoma A375 cell line that stably expresses the GFP-LC3-RFP probe. The GFP-LC3 is incorporated into autophagosomes, while RFP serves an internal control. The GFP/RFP fluorescence intensity ratio gives an accurate indication of autophagy induction (low ratio) vs blockage of autophagy flux (high ratio), and was validated with the autophagy inducer Torin1 and inhibitor Bafilomycin A Abbreviations: Baf, Bafilomycin A

Indexed as

FDA drugsGFP-LC3-RFPHigh content screeningMicrosource spectrum librarymTOR

Identifiers

PMID40396033
PMCPMC11864668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.